• Wed news: Lilly’s 4.5B medicine foundry project. 5 FDA decisions to watch in Q4. Hurricane Helene and the health supply chain. Lundbeck taps Charles River for AI-enabled neuro drug discovery. Amgen tax evasion lawsuit. See more on our front page

Friday RX numbers out for Viekira Pak

Anonymous

Guest
@H3NPHLO: #Viekira: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 870 NRx@ 536. $ABBV
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 413. NRx@ 216. $ABBV

@H3NPHLO: #Harvoni: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 10,080 NRx@ 4,535. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 9,795. NRx@ 3,799. $GILD

@H3NPHLO: #Sovaldi: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 2,060 NRx@ 868. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 1,916. NRx@ 700. $GILD

Follow on Twitter.
 

<



@H3NPHLO: #Viekira: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 870 NRx@ 536. $ABBV
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 413. NRx@ 216. $ABBV

@H3NPHLO: #Harvoni: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 10,080 NRx@ 4,535. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 9,795. NRx@ 3,799. $GILD

@H3NPHLO: #Sovaldi: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 2,060 NRx@ 868. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 1,916. NRx@ 700. $GILD

Follow on Twitter.

Another pitiful week of Rx performance!! Ricky earn your salary and DO something/anything!! Abby Retirees United
 




































@H3NPHLO: #Viekira: Prescr. figures for wk ending 4/10 (Symphony/BBG) : TRx@ 789 NRx@ 437. $ABBV
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 344 NRx@ 159. $ABBV

@H3NPHLO: #Harvoni: Prescr. figures for wk ending 4/10 (Symphony/BBG) : TRx@ 9,730 NRx@ 4,102. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 10,071 NRx@ 3,841. $GILD

@H3NPHLO: #Sovaldi: Prescr. figures for wk ending 4/10 (Symphony/BBG) : TRx@ 1,997 NRx@ 731.
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 1,837 NRx@ 591. $GILD

geno 1 MS 5% VK 95% Harv
 




@H3NPHLO: #Viekira: Prescr. figures for wk ending 4/10 (Symphony/BBG) : TRx@ 789 NRx@ 437. $ABBV
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 344 NRx@ 159. $ABBV

@H3NPHLO: #Harvoni: Prescr. figures for wk ending 4/10 (Symphony/BBG) : TRx@ 9,730 NRx@ 4,102. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 10,071 NRx@ 3,841. $GILD

@H3NPHLO: #Sovaldi: Prescr. figures for wk ending 4/10 (Symphony/BBG) : TRx@ 1,997 NRx@ 731.
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 1,837 NRx@ 591. $GILD

geno 1 MS 5% VK 95% Harv

We went down from last week! WTH is our sale force doing? NOTHING!!!!!!!
 








Big deal! Harvoni numbers went down too. Our product SUCKS. Nobody wants it unless forced by ESI. Even then, they get 1 rx and don't refill that piece of crap.

Now, let's blame the real cause of this situation. Every single person in Abbott Park that touched VPak should be fired. Dump the drug amd don't blame the reps. We would have 0 rx's if we didnt have such stellar reps working hard. This dog is hard to spell, sell, and smell! Piece of crap!!!
 




Big deal! Harvoni numbers went down too. Our product SUCKS. Nobody wants it unless forced by ESI. Even then, they get 1 rx and don't refill that piece of crap.

Now, let's blame the real cause of this situation. Every single person in Abbott Park that touched VPak should be fired. Dump the drug amd don't blame the reps. We would have 0 rx's if we didnt have such stellar reps working hard. This dog is hard to spell, sell, and smell! Piece of crap!!!

I agree 110%. The company cherry picked the best reps and MSLs in the industry. I would bet that half of the VPak scripts that have been written wouldn't have had the reps not been in theface of the providers.

This dog is not only hard to sell but even tougher to give away. How many providers are refusing the vouchers and making up bogus excuses. I heard one the other day. A provider said he didn't want the voucher because he didn't want the word getting out on the street that he gives away free medicine.

And the voucher program is a disaster. The providers are using it mainly for those who they couldn't get Harvoni approved. Very few GT 1As. And these patients are on concomitant meds that we didn't study and are not listed in hep-druginteractions.org
 




I agree 110%. The company cherry picked the best reps and MSLs in the industry. I would bet that half of the VPak scripts that have been written wouldn't have had the reps not been in theface of the providers.

This dog is not only hard to sell but even tougher to give away. How many providers are refusing the vouchers and making up bogus excuses. I heard one the other day. A provider said he didn't want the voucher because he didn't want the word getting out on the street that he gives away free medicine.

And the voucher program is a disaster. The providers are using it mainly for those who they couldn't get Harvoni approved. Very few GT 1As. And these patients are on concomitant meds that we didn't study and are not listed in hep-druginteractions.org

More excuses
 












@H3NPHLO: #Viekira: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 870 NRx@ 536. $ABBV
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 413. NRx@ 216. $ABBV

@H3NPHLO: #Harvoni: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 10,080 NRx@ 4,535. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 9,795. NRx@ 3,799. $GILD

@H3NPHLO: #Sovaldi: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 2,060 NRx@ 868. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 1,916. NRx@ 700. $GILD

Follow on Twitter.

What stock do you put in Friday's numbers Vs. Monday's numbers?
 








Similar threads

Replies
8
Views
2K
AbbVie
anonymous
Replies
16
Views
3K
AbbVie
anonymous
Replies
57
Views
7K
AbbVie
Anonymous
Replies
42
Views
3K
AbbVie
Anonymous